Mathieu Lupien
Professor, Dept. of Medical Biophysics University of Toronto
Toronto, ON
Dr. Mathieu Lupien is a Senior Scientist at the Princess Margaret Cancer Centre (PM), a Professor at the University of Toronto (Canada) and holds a cross-appointment with the Ontario Institute for Cancer Research (OICR). He serves on the Senior Advisory Group and the Research Council on Oncology to the Princess Margaret Cancer Centre.
Dr. Lupien’s research in chromatin & epigenetics has pioneered the study of the non-coding genome to identify determinants of oncogenesis and accelerated the development of chromatin & epigenetic-based precision medicine against cancer. Dr. Lupien earned his Ph.D. in experimental medicine at McGill University under the leadership of Dr. Sylvie Mader and carried out postdoctoral training in medical oncology as an Era of Hope Fellow at the Dana-Farber Cancer Institute under the mentorship of Dr. Myles Brown followed by an executive education at Harvard Business School. He joined the Princess Margaret Cancer Centre and the University of Toronto in 2012.
Among other honours, Dr. Lupien is a recipient the Canadian Cancer Society Bernard and Francine Dorval Award for Excellence, is a two times recipient of the Till and McCulloch Discovery of the Year award and of the Investigator Award from the OICR.